| Date Filed | Type | Description |
| 05/03/2011 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 04/19/2011 |
SC 13G/A
| CPEX Pharmaceuticals, Inc. reports a 0% stake in CPEX Pharmaceuticals, Inc. |
| 04/18/2011 |
SC 13G/A
| CPEX Pharmaceuticals, Inc. reports a 5.5% stake in CPEX Pharmaceuticals, Inc. |
| 04/07/2011 |
4
| Bergenhem Nils (Chief Scientific Officer) has filed a Form 4 on CPEX Pharmaceuticals, Inc.|
Txns:
| Exercised 17,500 shares
@ $0
Paid exercise price by delivering 10,018 shares
@ $27.25, valued at
$273k
Disposed/sold 13,875 shares
@ $0
Exercised 17,500 options to buy
@ $15.6, valued at
$273k
|
|
| 04/07/2011 |
4
| Berman Lance (Chief Medical Officer) has filed a Form 4 on CPEX Pharmaceuticals, Inc.|
Txns:
| Exercised 48,306 shares
@ $0
Paid exercise price by delivering 12,847 shares
@ $27.25, valued at
$350.1k
Disposed/sold 49,253 shares
@ $0
Exercised 45,000 options to buy
@ $7.045, valued at
$317k
Exercised 3,306 options to buy
@ $10, valued at
$33.1k
|
|
| 04/07/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/07/2011 |
4
| Hebert Robert P (CFO) has filed a Form 4 on CPEX Pharmaceuticals, Inc. |
| 04/07/2011 |
4
| MURPHY JAMES R (Director) has filed a Form 4 on CPEX Pharmaceuticals, Inc. |
| 04/07/2011 |
4
| Forrester Robert (Director) has filed a Form 4 on CPEX Pharmaceuticals, Inc. |
| 04/07/2011 |
4
| SPIEGEL JOHN W (Director) has filed a Form 4 on CPEX Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 1,500 shares
@ $0
Disposed/sold 5,600 restricted stock units
@ $0
Disposed/sold 3,000 options to buy
@ $9.9929, valued at
$30k
Disposed/sold 2,000 options to buy
@ $9.0142, valued at
$18k
Disposed/sold 2,000 options to buy
@ $11.2229, valued at
$22.4k
Disposed/sold 2,000 options to buy
@ $9.6831, valued at
$19.4k
Disposed/sold 5,000 options to buy
@ $17.205, valued at
$86k
|
|
| 04/07/2011 |
4
| MCGOVERN MICHAEL (Director) has filed a Form 4 on CPEX Pharmaceuticals, Inc. |
| 04/05/2011 |
8-K
| Quarterly results |
| 04/05/2011 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 04/05/2011 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 04/05/2011 |
BW
| CPEX Completes Sale to FCB I Holdings |
| 04/05/2011 |
SC 13G
| CPEX Pharmaceuticals, Inc. reports a 12% stake in CPEX Pharmaceuticals, Inc. |
| 04/05/2011 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 03/31/2011 |
10-K
| Annual Report for the period ended December 31, 2010 |
| 03/30/2011 |
8-K
| Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits |
| 03/24/2011 |
BW
| CPEX Stockholders Approve $27.25 Per Share Merger Agreement with FCB I Holdings |
| 03/23/2011 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 03/23/2011 |
BW
| CPEX Urges Stockholders to Consider the Facts of the Certain All-Cash FCB Transaction |
| 03/22/2011 |
PRN
| Mangrove Partners Notes CPEX Stock Trading Above Offer Price |
| 03/21/2011 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| 03/21/2011 |
PRN
| Mangrove Partners Expresses Disappointment in Board of CPEX Pharmaceuticals, Inc. and Reaffirms Proposed Recapitalization and Intention to Vote Against Merger |
| 03/18/2011 |
8-K
| Other Events, Financial Statements and Exhibits |
| 03/18/2011 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| 03/18/2011 |
BW
| CPEX Pharmaceuticals Affirms Recommendation That Stockholders Vote for Merger Agreement With FCB |
| 03/17/2011 |
8-K
| Other Events, Financial Statements and Exhibits |
| 03/17/2011 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| 03/17/2011 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| 03/17/2011 |
SC 13D/A
| CPEX Pharmaceuticals, Inc. reports a 6.3% stake in CPEX Pharmaceuticals, Inc. |
| 03/17/2011 |
BW
| CPEX Pharmaceuticals Advises Stockholders to Take No Action at This Time in Response to Mangrove Partners' Revised Proposal |
| 03/17/2011 |
BW
| CPEX Pharmaceuticals Continues to Recommend That Stockholders Vote for the Merger Agreement with FCB |
|